Vaccine News and Research

Latest Vaccine News and Research

Experts discuss antibiotic resistance, tuberculosis, malaria, vaccines, maternal mortality, childhood diseases and health sector reform

New challenges ahead and the unfinished agenda in public health in the Americas" will be the focus of joint efforts by the Pan American Health Organization (PAHO) and the U.S. Agency for International Development (USAID)

14 Sep 2004

ID Biomedical to supply meningitis C vaccine to the Canadian government

The Canadian government has retained an option to purchase additional product from the Company in the third and final year of the contract. The total value of the contract, including the third year option, could total approximately $30 million to ID Biomedical.

14 Sep 2004

New insights into the international burden of malaria

Malaria research scientists from around the globe have published new insights into the international burden of malaria and what can be done about it.

14 Sep 2004

Intelligent transit box keeps vaccinations cool

Vaccination supplies can be rendered useless if their temperature rises above the permitted maximum. MEDICASE has developed an intelligent transit box which ensures tight temperature control and which has a built-in data logger to provide a temperature audit trail.

14 Sep 2004

Early success of the meningococcal B immunisation programme celebrated

Experts in science and medicine will focus on New Zealand's Meningococcal B Immunisation Programme today and tomorrow at an Immunisation Conference in Rotorua.

10 Sep 2004

Evidence that measles-mumps-rubella immunisation is not associated with autism

A UK study published in this week’s issue of THE LANCET provides further evidence that measles-mumps-rubella (MMR) immunisation is not associated with the development of autism or other pervasive developmental disorders (PDDs) in children.

9 Sep 2004

Pneumococcal vaccine reduces the incidence of middle ear infection and pneumonia

Infection with Streptococcus pneumoniae bacteria can cause serious illness and death. Invasive pneumococcal disease is responsible for about 200 deaths each year among children under 5 years old.

8 Sep 2004

No discernible link between the three-in-one vaccine and child behavioural problems

A new study of children’s behaviour problems has come to the conclusion that there is no discernible link with the three-in-one vaccine now being phased out in the UK.

8 Sep 2004

50 year old frozen smallpox vaccines are nearly 100 percent effective

Diluted doses of a smallpox vaccine, originally manufactured in the 1950s and stored as a frozen preparation, are nearly 100 percent effective, allowing for expansion of the current stockpile if needed, according to an article in the September 8 issue of JAMA.

8 Sep 2004

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac Biotech Ltd. has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with two doses of either SARS vaccine or placebo.

7 Sep 2004

Pediatricians feel that universal influenza vaccination for infants is feasible

Most pediatricians and family physicians who completed a nationwide survey agreed that universal influenza vaccination for infants is feasible, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.

7 Sep 2004

Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction

A new University of Michigan study has found that the Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction in 1995 by preventing the kinds of severe cases that used to send children, teens and adults to the hospital.

7 Sep 2004

Researchers have successfully produced small quantities of a new vaccine for anthrax using Bacillus bacteria

Tiny types of soil bugs already make many of the products we use in washing detergents, foods, and waste treatment, but scientists now hope that similar bacteria will also make the vaccines and drugs of the future

7 Sep 2004

More than 100 million doses of influenza vaccine available this year in the United States

Despite an Aug. 26 announcement that some doses of influenza vaccine to the United States have been delayed, the Centers for Disease Control and Prevention said the effects of the delay will be minimal - and physicians do not need to order more doses.

5 Sep 2004

Researchers unravel genetic makeup of ticks to tackle disease

Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.

4 Sep 2004

Researchers make discoveries on West Nile virus, monkeypox, and yellow fever

Researchers from the University of Texas Medical Branch at Galveston present significant new discoveries on West Nile virus, monkeypox, and yellow fever

4 Sep 2004

Compulsory vaccination against terrorist attack is unjustified

The compulsory use of vaccines to prevent the effects of a bioterrorist attack seems to be based on an unproved threat, according to an editorial in this week's BMJ.

4 Sep 2004

World needs to commit more resources to treat people infected with HIV

Leaders of the International AIDS Vaccine Initiative (IAVI) have stressed that as the world commits more resources to treat people infected with HIV, it must also intensify efforts to develop a vaccine to prevent new infections and stop the continuing spread of the virus.

2 Sep 2004

More women and adolescents needed in HIV vaccine clinical trials

Greater participation of women and adolescents is needed in HIV vaccine clinical trials, according to a group of international experts, who attended a consultation on HIV vaccine trials in Lausanne, Switzerland, from 26-28 August.

1 Sep 2004

Scientists to tackle the most common cause of diarrhoea world-wide with DNA sequencing

Returning holidaymakers may be comforted to know that travellers' diarrhoea could be a thing of the past. Scientists at the University of Birmingham's Medical School are set to sequence the DNA of the bacterium: this will identify causes of illness and point to better cures.

31 Aug 2004